What is the appropriate evaluation and treatment for a new bald spot on a 10-year-old girl?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Evaluation and Management of a New Bald Spot in a 10-Year-Old Girl

The most likely diagnosis is alopecia areata, which can be diagnosed clinically without laboratory testing in most cases, and watchful waiting with reassurance is a legitimate first-line approach since 34-50% of children with limited patchy hair loss recover spontaneously within one year. 1, 2

Initial Clinical Assessment

Key Diagnostic Features to Examine

  • Look for exclamation mark hairs at the margins of the bald patch—these are short broken hairs (2-3mm) that are pathognomonic for alopecia areata and can be identified with dermoscopy 1, 2

  • Assess the pattern of hair loss: discrete round or oval patches indicate alopecia areata, while incomplete hair loss with firmly anchored broken hairs suggests trichotillomania 1, 2

  • Check for scalp inflammation or scaling: if present, this suggests tinea capitis rather than alopecia areata, which typically shows smooth skin without inflammation 1, 2

  • Examine for yellow dots on dermoscopy: regular round yellow dots are commonly seen in active alopecia areata and indicate disease progression 1

Essential History Elements

  • Duration of hair loss: onset less than 1 year predicts better prognosis with potential spontaneous remission in 34-50% of cases 1, 2

  • Family history: approximately 20% of children with alopecia areata have a family history of the condition 1, 2

  • Assess for hair pulling behaviors: trichotillomania must be differentiated from alopecia areata, as management differs completely 1, 3

Laboratory Testing Strategy

Investigations are unnecessary in most cases when alopecia areata is clinically evident. 1, 2

When to Order Tests

  • Fungal culture: only if tinea capitis is suspected based on scalp inflammation or scaling 1, 2

  • Skin biopsy: reserved for uncertain diagnosis or suspected scarring alopecia 1, 2

  • Avoid routine autoimmune panels: the increased frequency of autoimmune disease in alopecia areata patients is insufficient to justify routine screening 1, 2

Treatment Algorithm

First-Line Approach: Watchful Waiting

For limited patchy alopecia areata (single or few patches), watchful waiting with reassurance is the recommended initial approach. 1, 2

  • Spontaneous remission occurs in 34-50% of patients within one year without any treatment 1, 2

  • Counsel that regrowth cannot be expected within 3 months of any individual patch development 1, 2

  • No treatment has been shown to alter the long-term course of alopecia areata, though some can induce temporary hair regrowth 1, 2

Second-Line: Active Treatment (If Desired)

If treatment is requested after discussion, intralesional corticosteroids are the most appropriate option for limited patchy disease. 1, 2

  • Use triamcinolone acetonide 5-10 mg/mL injected just beneath the dermis in the upper subcutis 1

  • Each 0.05-0.1 mL injection produces a tuft of hair growth approximately 0.5 cm in diameter, with effects lasting about 9 months 1

  • In one study, 62% of patients achieved full regrowth with monthly injections, with better response in those with fewer than five patches less than 3 cm in diameter 1

  • Main limitation is patient discomfort from multiple injections 1

Treatments to Avoid in Children

  • Potent topical corticosteroids lack convincing evidence of effectiveness for alopecia areata 1, 2

  • Systemic corticosteroids are not recommended due to potentially serious side-effects and inadequate efficacy evidence, though some recent data suggest oral betamethasone mini-pulses may have a role in severe cases 1, 4

  • Oral zinc and isoprinosine are ineffective in controlled trials 2

Psychological Support

Assessment of psychological impact is essential, as children with alopecia areata commonly experience self-consciousness, embarrassment, and bullying 1, 5

  • Psychological interventions should be offered to improve coping mechanisms 1

  • Parents should be offered psychological counseling as well 1

  • Wigs can provide immediate cosmetic benefit if hair loss is extensive or distressing 2

Common Pitfalls to Avoid

  • Do not order extensive autoimmune panels in straightforward alopecia areata cases—this is unnecessary and not recommended 1, 2

  • Do not miss trichotillomania: broken hairs in trichotillomania remain firmly anchored (still in anagen phase), unlike exclamation mark hairs in alopecia areata 1, 2

  • Do not promise rapid results: patients must understand that even with treatment, regrowth takes at least 3 months 1, 2

  • Do not use hazardous treatments of unproven efficacy: alopecia areata has no direct impact on general health that justifies risky interventions 1, 6

Prognosis Counseling

  • Patients with less than 25% hair loss initially have a 68% chance of being free of disease at follow-up 1

  • Long-standing extensive alopecia has a poor prognosis, and many patients prefer no active treatment other than wearing a wig 1, 6

  • Relapse can occur even after successful treatment, and patients should be forewarned about this possibility 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Hair Loss

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

European expert consensus statement on the systemic treatment of alopecia areata.

Journal of the European Academy of Dermatology and Venereology : JEADV, 2024

Guideline

Treatment Options for Diffuse Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.